Manuscripts
October 18, 2023
Natural history and real-world treatment outcomes for non-small cell lung cancer patients with EGFR exon 20 insertion mutation: An IASLC- ASCO CancerL…
JTO Clin Res Rep
Behera M et al
September 20, 2023
Real-world pitfalls of analyzing real-world data: A cautionary note and path forward
JCO Clinical Cancer Informatics
Cooper J et al
August 30, 2023
Prognostic impact of second primary malignancies in multiple myeloma: An ASCO CancerLinQ Discovery analysis of the modern era [CORRESPONDENCE]
American Journal of Hematology
Gibson S et al
July 28, 2023
Multiple myeloma in adolescent and young adults: An ASCO CancerLinQ and SEER analysis
Clinical Lymphoma, Myeloma and Leukemia
Gibson S et al
May 23, 2023
Health data sharing perspectives of patients receiving care in CancerLinQ-participating oncology practices
JCO Oncology Practice
Jagsi R et al
March 26, 2023
Real-world big-data: Strengths and weaknesses of ASCO's CancerLinQ Discovery® multiple myeloma dataset
American Journal of Hematology
DeStefano CB
February 22, 2023
Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected EGFR mutation-positive non-small cell lung cancer
PharmacoEconomics - Open
Verhoek A et al
January 10, 2023
Challenges to using big data in cancer
Cancer Research
Sweeney SM et al
January 10, 2023
Case studies for overcoming challenges in using big data in cancer
Cancer Research
Sweeney SM et al
Abstracts
December 7, 2023
Disparities in genetic testing patterns and positivity among patients with breast cancer in the CancerLINQ real-world oncology database [Poster PO4-08…
2023 San Antonio Breast Cancer Symposium
Kantor O
October 27, 2023
Implementing a BRAF biomarker electronic clinical quality measure in CancerLinQ
2023 ASCO Quality Care Symposium
Drumheller C
October 27, 2023
Uptake and efficacy of immuno-oncology combinations in metastatic renal cell carcinoma in the United States: Evidence from the ASCO CancerLinQ Discove…
2023 ASCO Quality Care Symposium
Vento J
June 2, 2023
Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery Multiple Myeloma dataset
ASCO Annual Meeting 2023
Shou K J et al
June 2, 2023
A real-world study of US patients with metastatic ovarian, fallopian tube, and peritoneal cancer (mOFPC) using integrated electronic health records (E…
ASCO Annual Meeting 2023
Avinash P B et al
June 2, 2023
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC withou…
ASCO Annual Meeting 2023
Gray J E et al
June 2, 2023
Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets
ASCO Annual Meeting 2023
McKelvey B A et al
June 2, 2023
Electronic health record (EHR) and genomics-based machine learning (ML) to predict therapeutic effectiveness among patients with hormone-receptor posi…
ASCO Annual Meeting 2023
Hathi D et al
June 2, 2023
Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-…
ASCO Annual Meeting 2023
Naidoo J et al